These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 5260856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
    Ionescu V.
    Dtsch Med Wochenschr; 1971 May 14; 96(20):867-70. PubMed ID: 5280862
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
    Sullivan JR, Hurley TH, Bolton JH.
    Cancer Treat Rep; 1977 May 14; 61(1):43-5. PubMed ID: 266418
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.
    Ferrara F, Palmieri S, Annunziata M, Viola A, Pocali B, Califano C, D'Arco AM, Mele G.
    Bone Marrow Transplant; 2004 Oct 14; 34(7):573-6. PubMed ID: 15258559
    [Abstract] [Full Text] [Related]

  • 8. The possibility of radical chemotherapy in chronic myelocytic leukaemia.
    Galton DA.
    Haematol Lat; 1969 Oct 14; 12(3):703-9. PubMed ID: 5273182
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of chronic myeloid leukemia with dibromomannitol].
    Clément F, Saillen R.
    Schweiz Med Wochenschr; 1970 Nov 14; 100(46):1995-7. PubMed ID: 5279364
    [No Abstract] [Full Text] [Related]

  • 10. [Therapy of the blastic crisis].
    Tura S, Baccarani M, Bagnara GP.
    Minerva Med; 1972 Mar 31; 63(24):1459-67. PubMed ID: 4502509
    [No Abstract] [Full Text] [Related]

  • 11. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2000 Oct 31; 26(7):711-6. PubMed ID: 11042650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Differential diagnosis of atypical chronic myeloid leukaemia].
    Klein UE, Schwarze EW, Schwalbe P, Tolksdorf ME.
    Dtsch Med Wochenschr; 1976 Jun 11; 101(24):915-20. PubMed ID: 1064523
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Pulmonary fibrosis after busulfan therapy].
    Jandl H, Franke A, Albrecht G.
    Z Gesamte Inn Med; 1975 Dec 15; 30(24):799-801. PubMed ID: 1062873
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Aplastic syndrome in myleran overdose].
    Albrecht M, Tackmann W, Pribilla W.
    Med Klin; 1971 Jan 22; 66(4):126-30. PubMed ID: 5278287
    [No Abstract] [Full Text] [Related]

  • 20. [Pregnancy during busulfan therapy of chronic granulocytic leukemia].
    Szentcsíki M, Brenner F, Balogh C, Hites L.
    Orv Hetil; 1982 May 23; 123(21):1307-8. PubMed ID: 6955735
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.